ZIPRASIDONE MESYLATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for ziprasidone mesylate and what is the scope of patent protection?

Ziprasidone mesylate is the generic ingredient in two branded drugs marketed by Viatris, Gland Pharma Ltd, and MSN, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Seven suppliers are listed for this compound.

Summary for ZIPRASIDONE MESYLATE

US Patents:	0
Tradenames:	2
Applicants:	3
NDAs:	3
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	56
Clinical Trials:	1
Patent Applications:	277
What excipients (inactive ingredients) are in ZIPRASIDONE MESYLATE?	ZIPRASIDONE MESYLATE excipients list
DailyMed Link:	ZIPRASIDONE MESYLATE at DailyMed

Recent Clinical Trials for ZIPRASIDONE MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Yang Fude	Phase 4
Pfizer	Phase 4

See all ZIPRASIDONE MESYLATE clinical trials

Pharmacology for ZIPRASIDONE MESYLATE

Drug Class	Atypical Antipsychotic

Anatomical Therapeutic Chemical (ATC) Classes for ZIPRASIDONE MESYLATE

N05AE	Indole derivatives
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for ZIPRASIDONE MESYLATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gland Pharma Ltd	ZIPRASIDONE MESYLATE	ziprasidone mesylate	POWDER;INTRAMUSCULAR	211908-001	Dec 26, 2019	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Msn	ZIPRASIDONE MESYLATE	ziprasidone mesylate	POWDER;INTRAMUSCULAR	216091-001	Sep 15, 2022	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ZIPRASIDONE MESYLATE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Sign Up	⤷ Sign Up
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Sign Up	⤷ Sign Up
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Sign Up	⤷ Sign Up
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Sign Up	⤷ Sign Up
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Sign Up	⤷ Sign Up
Viatris	GEODON	ziprasidone mesylate	POWDER;INTRAMUSCULAR	020919-001	Jun 21, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.